GLAND PHARMA
|
The Current P/S Ratio of GLAND PHARMA is 5.57.
Share Price | ₹1,933.0 | Aug 08,2025 |
Market Cap | ₹31,855.8 Cr | |
Sales-TTM | ₹5,720.4 Cr | TTM-Consolidated Results |
Price/Sales | 5.57x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLAND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹31,855.8 Cr] as on Aug 08,2025
(/) Sales [ ₹5,720.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.57x ]
Thus, for GLAND PHARMA , the investors are currently willing to pay '5.57 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLAND PHARMA !
The chart below summarizes the trend in P/S Ratio of GLAND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of GLAND PHARMA
PS Ratio Performance Analysis for GLAND PHARMA
- GLAND PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.94x.
- GLAND PHARMA 's operated at median p/e ratio of 5.76x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/e ratio peaked in Mar2022 at 12.21x.
- GLAND PHARMA 's p/e ratio hit its five-year low in Mar2025 of 4.67x.
How does GLAND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLAND PHARMA | 5,720.4 | 5.57 | 31,855.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.08 | 380,702.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.26 | 156,908.0 |
CIPLA LTD | 27,811.2 | 4.31 | 119,988.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.22 | 120,896.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.02 | 101,122.0 |
MANKIND PHARMA LTD | 12,956.2 | 7.86 | 101,775.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.05 | 94,133.2 |
LUPIN LTD | 23,375.9 | 3.75 | 87,547.0 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.89 | 60,499.2 |
ABBOTT INDIA LTD | 6,409.2 | 10.88 | 69,749.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAND PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.89x |
Max industry PS | 16.26x |
Median industry PS | 5.57x |
Average industry PS | 6.81x |
You may also like the below Video Courses